Cadila Pharmaceuticals, a privately held pharmaceutical company, has been acknowledged at the CII Industrial Innovation Awards 2023 as one of the ‘Top 50 Innovative Companies of India.’
On December 15, Raj Prakash Vyas, president of Corporate Affairs at Cadila Pharmaceuticals, received the award on behalf of the company at a ceremony attended by key opinion leaders and notable figures from India’s corporate realm.
The event was graced by personalities such as Parvinder Maini, scientific secretary at the office of the principal scientific adviser to the government of India, Vipin Sondhi, chairman of CII Industrial Innovation Awards 2023, and Alok Nanda, co-chairman of CII Industrial Innovation Awards 2023.
Among the innovations from Cadila showcased were Rabeloc IV, Sepsivac, Polycap, Resorine, Cadiflu, MycidacC, ThRabis, and others. These innovations, . Vyas emphasized, represent the company’s commitment to advancing healthcare solutions.
“At Cadila Pharmaceuticals, our focus on innovation is not just about creating medicines; it’s about catalyzing positive change. Our innovations are designed to address critical public health problems, contributing to a healthier and more resilient society,” Vyas said.
The CII Industrial Innovation Awards, instituted in 2014, serve to identify and celebrate innovative enterprises across diverse industry segments in India. These awards provide a platform for companies to gain national and international recognition for their innovative products and services.
Recognized as one of the most coveted innovation awards in the country, the CII Industrial Innovation Awards not only honor innovation champions in Indian industry but also enhance their competitiveness in both domestic and global markets. Cadila Pharmaceuticals stands proud as a beacon of innovation in the pharmaceutical landscape, embodying excellence and commitment to healthcare advancement.
Established in 1951, Cadila Pharmaceuticals has consistently focused on creating innovative and affordable healthcare solutions for people worldwide.